Gyon Technologies Capital Management, LP Immatics N.V. Transaction History

Gyon Technologies Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$8.05 - $11.58 $242,466 - $348,789	30,120 Added 238.07%	42,772 $372,000
Q3 2022 Nov 14, 2022	BUY	$3.31 - $13.06 $41,878 - $165,235	12,652 New	12,652 $127,000
Q1 2022 May 12, 2022	SELL	$6.64 - $12.85 $215,288 - $416,635	-32,423 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$10.81 - $14.38 $350,492 - $466,242	32,423 New	32,423 $436,000

101

75.8M

238K

727K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $566M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.